Guggenheim downgraded IGM Biosciences (IGMS) to Neutral from Buy.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IGMS:
- IGM Biosciences downgraded to Sector Perform from Outperform at RBC Capital
- IGM Biosciences downgraded to Hold from Buy at Stifel
- IGM Biosciences downgraded to Underweight from Equal Weight at Morgan Stanley
- IGM Biosciences downgraded to Market Perform from Outperform at BMO Capital
- IGM Biosciences reducing workforce by 73%, evaluating strategic alternatives